Biosector 2

What Biosector 2 does

Biosector 2 (B2) is a pure-play healthcare communications agency founded in 2002 and headquartered in New York, with a second office in London. The firm operates as a wholly-owned subsidiary within the Syneos Health Communications network, which aggregates ten specialized agencies covering advertising, branding, medical communications, market access, and public relations for healthcare clients. B2 delivers an integrated communications offering across fifteen service lines, including PR strategy, product and milestone communications, disease awareness, media relations, advocacy relations, influencer and celebrity strategy, scientific storytelling, digital and social strategy, corporate affairs, reputation management, value and access, DE&I and health equity, social impact and ESG, creative services, and research and analytics.

The company's technical differentiators are the proprietary METRIC Model — used to track and measure difficult-to-measure engagement activities over time — and the Dialogue RoadMAP, a digital strategy framework combining behavioral insights with social listening. These methodologies underpin B2's campaign measurement and audience strategy work, supported by a five-year track record spanning 46 therapeutic areas, 74 patient advocacy relationships, and 531 influencers engaged. The firm operates enterprise B2B project-and-retainer engagements primarily with pharmaceutical, biotech, and healthcare clients; two-thirds of its client base consists of small and mid-size biotech companies (SMID), with the remainder split across large pharma and patient advocacy organizations.

Commercially, B2 monetizes through custom professional-services engagements with no publicly disclosed pricing. Go-to-market relies on direct enterprise sales supported by Syneos Health network referrals, participation in approximately 16 medical meetings per year, thought-leadership content, and the firm's employer brand (recognized on PRWeek's Best Places to Work in 2024 and 2025 and PRovoke Media's 100 Best Agencies in the U.S. in 2026). Annual revenue, funding history, and detailed financial metrics are not disclosed; the company is private and operates within the Syneos Health corporate umbrella.

Name

Biosector 2

Legal name

Biosector 2

Website

https://biosector2.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

Biosector 2 is a pure-play healthcare communications agency within the Syneos Health Communications network, serving pharmaceutical, biotech, and healthcare clients — primarily small and mid-size biotech — across fifteen integrated service lines including PR, media relations, influencer marketing, advocacy relations, and behaviorally-informed digital strategy.

Ownership category

akta.pro rank

Product category

Healthcare Communications Services

NAICS

Other Scientific and Technical Consulting Services (54169)

akta.pro primary industry

Healthcare & Life Sciences PR (MPAAADAD)

akta.pro secondary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Healthcare communications services
• Pharmaceutical public relations
• Medical communications agency
• Disease awareness campaigns
• Biotech public relations

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Healthcare Communications Services: Professional services revenue from healthcare communications, PR strategy, media relations, scientific storytelling, and campaign execution for pharmaceutical and healthcare clients. Agency operates on project-based and retainer fee structures typical of healthcare PR agencies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Biosector 2 is a pure-play healthcare communications agency that provides integrated PR, media relations, disease awareness, scientific storytelling, influencer strategy, advocacy relations, corporate affairs, reputation management, value & access, DE&I/health equity, social impact/ESG, creative, and research & analytics services to pharmaceutical, biotech, and healthcare clients. The agency operates as part of the Syneos Health Communications network and delivers behavioral insights-backed campaigns that connect client science to societal priorities across the full asset lifecycle.

Product overview

Biosector 2 is a pure-play healthcare communications agency that offers a comprehensive suite of integrated communication services rather than a software product platform. The agency provides 15 distinct service offerings including PR Strategy, Product/Data/Milestone Communications, Disease Awareness, Media Relations, Advocacy Relations, Influencer and Celebrity Strategy, Scientific Storytelling, Digital and Social Strategy, Corporate Affairs, Reputation Management, Value & Access, DE&I and Health Equity, Social Impact/ESG, Creative Services, and Research and Analytics. These services work together as a unified communications offering backed by the Syneos Health network, designed to help pharmaceutical and healthcare clients connect their science to societal priorities through behavioral insights-backed campaigns.

Differentiator

Problem solved

Functional benefit

Products and services

• PR Strategy

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Syneos Health CommunicationscoreStrategic or Co-development PartnerB2 is part of Syneos Health Communications, a portfolio of innovative health-first, health-only advertising, branding, creative, medical communications, market access, and public relations agencies. This network provides B2 with access to global clinical and commercial expertise, behavioral sciences capabilities, and integrated communications strategies across multiple disciplines and geographies.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Chamberlain Healthcare Public Relations: A sister agency under Syneos Health Communications providing public relations and communications services to healthcare and pharmaceutical clients, directly competing with B2 for similar client mandates within the same parent network.
• Chandler Chicco Agency: A healthcare PR and communications agency within Syneos Health Communications, offering comparable services in health PR, advocacy relations, and corporate communications, directly competing with B2 within and outside the Syneos network.
• Real Chemistry: An independent healthcare communications and marketing agency (formerly W2O Group) serving pharmaceutical, biotech, and consumer health clients with PR, medical communications, and analytics capabilities closely paralleling B2's offerings.
• WE Communications: A global independent communications agency with a dedicated healthcare practice providing PR, patient advocacy, and scientific storytelling services to pharma and biotech clients, directly comparable to B2's core service mix.
• SPHERICO: A healthcare-focused public relations agency within Syneos Health Communications offering comparable communications services to pharma clients, representing internal network competition to B2 for similar client briefs.
• CMI Media Group: A healthcare-focused media and communications agency providing PR, influencer marketing, and media planning services to pharma clients, with comparable target customers and service capabilities to B2.

Broad incumbents

• Edelman (Healthcare practice): A global communications holding company with a large healthcare and health policy practice serving major pharmaceutical clients; broader in scope than B2 but directly competing for large pharma communications mandates.
• Ogilvy Health: The healthcare-focused arm of WPP's Ogilvy network offering PR, medical communications, and creative services to pharma clients; broader portfolio and global scale than B2 but overlapping on healthcare communications engagements.

Emerging players

• Precision Medicine Group: A specialized healthcare services group offering communications, medical affairs, and commercialization services to biotech and pharma clients, with growing overlap with B2 in pre-commercial and launch-stage communications.

Others

• Syneos Health Communications: The parent network housing B2 alongside sister agencies; provides integrated clinical and commercial communications capabilities and is the primary distribution and strategic ecosystem partner for B2's growth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biosector-2

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biosector 2